The largest database of trusted experimental protocols

Pmd2 g

Manufactured by VectorBuilder

The PMD2.G is a precision microcontroller device designed for accurate motion control applications. It features a high-performance processor, integrated motor drivers, and a range of customizable peripheral interfaces. The core function of the PMD2.G is to provide a flexible and reliable platform for precise control of various motors and actuators.

Automatically generated - may contain errors

2 protocols using pmd2 g

1

Lenti-X 293T HEK Cell Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seventy to ninety percent confluent Lenti-X 293T HEK cells cultured in DMEM 10% FBS media were transfected with pMD2.G and pCMVR8.74 alongside appropriate delivery plasmids: pLV[Exp]-U6 > sgRNA-hPGK > mApple (Vectorbuilder) plasmids (for sgRNA), empty pLVX-EF1α-IRES-Puro (Clontech, Takara Bio, 631988), V5-KANSL1 pLVX-EF1α-IRES-Puro or V5-KAT8 pLV[Exp]-EF1α-IRES-Puro at a 1:1:2 molar mass ratio using Lipofectamine 3000 (Invitrogen). The next day, a full media change was performed with mTeSR1 (for sgRNA lentivirus) or DMEM 10% FBS media and cells cultured for 24 h. The lentivirus containing mTeSR1/DMEM 10% FBS was collected and diluted 1:2 with fresh mTeSR1 or 10% FBS before filtering through 0.44 µm PES filters. pMD2.G (Addgene plasmid no. 12259, RRID:Addgene_12259) and pCMVR8.74 (Addgene plasmid #22036, RRID:Addgene_22036) were gifts from Didier Trono. KANSL1 cDNA (ENST00000432791.7) with N-terminal V5 tag was cloned into the pLVX-EF1α-IRES-Puro plasmid using SpeI and NotI restriction sites (doi:10.5281/zenodo.6903553). See Supplementary Table 1 for sgRNA plasmids and V5-KAT8 pLV[Exp]-EF1α-IRES-Puro plasmids (Vectorbuilder).
+ Open protocol
+ Expand
2

Lentivirus-Mediated CRISPR-Cas9 Screening in C2C12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Initially, the plasmids encoding Cas9 along with pMD2.G and psPAX2 lentiviral plasmids (VectorBuilder, Guangzhou, China) were transfected into 293T cells. After a 60 h incubation period, the supernatant containing the generated lentivirus was harvested and utilized to infect the target cells, C2C12. Subsequent to drug screening for positive cells, monoclonal cell sorting and expansion procedures were carried out, culminating in obtaining a C2C12 monoclonal cell line expressing Cas9. C2C12-Cas9 cells were seeded into T75 flasks and then infected with the library lentiviruses at a multiplicity of infection (MOI) of 0.3. Three days post-infection, GFP-positive cells were sorted using Fluorescence-Activated Cell Sorting (FACS), while puromycin-resistant cells were selected with 1.5 μg/mL puromycin. Subsequently, the sorted (1B) and selected cells (2B) were reseeded into T75 flasks. The cells would then be divided into two groups, one was collected after 1 day of proliferation and the other was collected when the cells were left for continuous proliferation in the growth medium for 5 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!